Kajiyama A - Search Results

1

Preliminary evaluation of polymer-based drug composite microparticle production by coacervate desolvation with supercritical carbon dioxide.

Yasuji T, Haslam J, Kajiyama A, McIntosh MP, Rajewski RA. Yasuji T, et al. Among authors: kajiyama a. J Pharm Sci. 2006 Mar;95(3):581-8. doi: 10.1002/jps.20565. J Pharm Sci. 2006. PMID: 16419052

2

Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form.

Mizumoto T, Tamura T, Kawai H, Kajiyama A, Itai S. Mizumoto T, et al. Among authors: kajiyama a. Chem Pharm Bull (Tokyo). 2008 Apr;56(4):530-5. doi: 10.1248/cpb.56.530. Chem Pharm Bull (Tokyo). 2008. PMID: 18379103 Free article.

3

In vitro stability and in vivo absorption studies of colloidal particles formed from a solid dispersion system.

Yano K, Kajiyama A, Yamazaki S, Matsumura Y, Watanabe K, Yamamoto K. Yano K, et al. Among authors: kajiyama a. Chem Pharm Bull (Tokyo). 1996 Dec;44(12):2309-13. doi: 10.1248/cpb.44.2309. Chem Pharm Bull (Tokyo). 1996. PMID: 8996862

4

Formulation design of an oral, fast-disintegrating dosage form containing taste-masked particles of famotidine.

Mizumoto T, Tamura T, Kawai H, Kajiyama A, Itai S. Mizumoto T, et al. Among authors: kajiyama a. Chem Pharm Bull (Tokyo). 2008 Jul;56(7):946-50. doi: 10.1248/cpb.56.946. Chem Pharm Bull (Tokyo). 2008. PMID: 18591807 Free article.

5

Improvement of HPMC tablet disintegration by the addition of inorganic salts.

Kajiyama A, Takagi H, Moribe K, Yamamoto K. Kajiyama A, et al. Chem Pharm Bull (Tokyo). 2008 Apr;56(4):598-601. doi: 10.1248/cpb.56.598. Chem Pharm Bull (Tokyo). 2008. PMID: 18379117 Free article.

6

Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.

Nakai Y, Yamamoto K, Terada K, Kajiyama A. Nakai Y, et al. Among authors: kajiyama a. Chem Pharm Bull (Tokyo). 1985 Nov;33(11):5110-2. doi: 10.1248/cpb.33.5110. Chem Pharm Bull (Tokyo). 1985. PMID: 3830437 No abstract available.

7

[Crystallinity changes of alpha- and beta-cyclodextrins by grinding].

Nakai Y, Yamamoto K, Terada K, Kajiyama A. Nakai Y, et al. Among authors: kajiyama a. Yakugaku Zasshi. 1985 Jun;105(6):580-5. Yakugaku Zasshi. 1985. PMID: 4067823 Japanese. No abstract available.

8

Inhibition of a solid phase reaction among excipients that accelerates drug release from a solid dispersion with aging.

Mizuno M, Hirakura Y, Yamane I, Miyanishi H, Yokota S, Hattori M, Kajiyama A. Mizuno M, et al. Among authors: kajiyama a. Int J Pharm. 2005 Nov 23;305(1-2):37-51. doi: 10.1016/j.ijpharm.2005.08.021. Epub 2005 Oct 13. Int J Pharm. 2005. PMID: 16226411

9

Different effects of carboxy-terminal deletion in the adrenodoxin molecule on cytochrome c and acetylated cytochrome c reductions.

Sagara Y, Hara T, Ariyasu Y, Kajiyama A, Yasukochi T, Horiuchi T. Sagara Y, et al. Among authors: kajiyama a. Biol Pharm Bull. 1996 Nov;19(11):1401-6. doi: 10.1248/bpb.19.1401. Biol Pharm Bull. 1996. PMID: 8951153 Free article.

10

Consistency and prognostic value of preoperative staging and postoperative pathological staging using ¹⁸F-FDG PET/MRI in patients with non-small cell lung cancer.

Kajiyama A, Ito K, Watanabe H, Mizumura S, Watanabe SI, Yatabe Y, Gomi T, Kusumoto M. Kajiyama A, et al. Ann Nucl Med. 2022 Dec;36(12):1059-1072. doi: 10.1007/s12149-022-01795-9. Epub 2022 Oct 20. Ann Nucl Med. 2022. PMID: 36264439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters